. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Tau Multimers as Therapeutic Target in Tauopathies

Reference #:

2007-063

Inventors/Contributors

Michael L. Hutton, Ph.D., Zdenek Berger, Ph.D.

Description

We define biochemical tau species, called tau multimers, in vivo both in mouse models of tauopathies and human tauopathies. The levels of these species are tightly linked to the extent of memory impairment as well as other deficits caused by tau. Our study identifies a therapeutic target for human tauopathies - these include strategies aimed at preventing the formation of these species or removing it.

Patent Status

None

Contact

Susan L. Stoddard, Ph.D., Licensing Manager
sstoddard@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 284-1222
Fax: (507) 284-5410